Atlas Trials

Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions

Clinical trial NCT02561650 · COMPLETED

Trial details

NCT number
NCT02561650
Sponsor
Mallinckrodt
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pharmacokinetics
Start date
2011-12-01
Primary completion
2011-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.